ESR1 and breast cancer: Previously, it was shown that CerK expression is higher in estrogen receptor (ER) negative than in ER positive breast cancer tissue, and that within the ER negative subgroup of patients, those with highest CerK expression had the worst prognosis and the shortest survival [21].